Daijiworld Media Network - Washington
Washington, Dec 11: The US Congress is moving forward with a tougher stance on China through the National Defense Authorization Act (NDAA), even as the Trump administration signals a softer approach to maintain stability in trade relations with Beijing.
The House on Wednesday passed a 3,000-page defense bill that includes strict provisions targeting Chinese military-linked technology development and reducing America’s dependence on Chinese biotechnology firms. The bill now awaits Senate approval.
A key provision will scrutinize US investments in China that could bolster Beijing’s military capabilities. Another clause prohibits federal funding for equipment or services from Chinese biotech firms deemed high-risk, leaving the task of drafting the list to the Office of Management and Budget.
The NDAA also strengthens US support for Taiwan, raising security cooperation funding from $300 million to $1 billion and directing the Pentagon to establish a joint drone and anti-drone program. Additionally, it backs Taiwan’s push for membership in the International Monetary Fund.
Rep. Raja Krishnamoorthi, senior Democrat on the House Select Committee on the Chinese Communist Party, said the measures reflect a “serious, strategic approach” to countering Beijing—one that stands in contrast to the White House’s more conciliatory tone.
The strong congressional action follows the Trump administration’s decision to soften language in its national security strategy and allow Nvidia to sell advanced chips to China, raising concerns among China hawks. Analysts say the bill underscores Capitol Hill’s commitment to a long-term, competitive posture toward Beijing, regardless of White House shifts.
China has sharply criticised the NDAA. Embassy spokesperson Liu Pengyu said the bill exaggerates the “China threat,” interferes in China’s internal affairs, and undermines efforts to stabilise relations.
The legislation also revives efforts to safeguard US biosecurity following the earlier failure of the BIOSECURE Act. While the new version avoids naming specific companies, it allows the government to blacklist Chinese biotech firms of concern and expands Pentagon investment in biotechnology.
The defense bill arrives at a time when President Trump appears cautious about upsetting Beijing as he pursues trade agreements with President Xi Jinping. Even so, the new national security strategy stresses preventing conflict in the Taiwan Strait, urging stronger defence contributions from US allies like Japan and South Korea.
If enacted, the bill would lay the foundation for enduring US policies aimed at countering China across technology, defense, and economic sectors.